A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia

Published:2002-06 Issue:2 Volume:162 Page:373-379
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Saito Yasushi,Yamada Nobuhiro,Teramoto Tamio,Itakura Hiroshige,Hata Yoshiya,Nakaya Noriaki,Mabuchi Hiroshi,Tushima Motoo,Sasaki Jun,Ogawa Nobuya

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism;Archives of Pharmacal Research;2023-12-30

2. Enhancement of the Solubility and Bioavailability of Pitavastatin through a Self-Nanoemulsifying Drug Delivery System (SNEDDS);Pharmaceutics;2022-02-22

3. Pitavastatin for lowering lipids;Cochrane Database of Systematic Reviews;2020-06-19

4. Naringin reduces body weight, plasma lipids and increases adiponectin levels in patients with dyslipidemia;International Journal for Vitamin and Nutrition Research;2020-06-09

5. An evaluation of pitavastatin for the treatment of hypercholesterolemia;Expert Opinion on Pharmacotherapy;2018-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP